NeuBase Therapeutics

$6.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.34 (-5.23%) As of 7:56 PM UTC today

Why Robinhood?

You can buy or sell NBSE and other stocks, options, and ETFs commission-free!

About NBSE

NeuBase Therapeutics, Inc. Common Stock, also called NeuBase Therapeutics, is a biotechnology company.

CEO
Dietrich A. Stephan
Employees
15
Headquarters
Pittsburgh, Pennsylvania
Founded
2018
Market Cap
154.87M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
276.10K
High Today
$6.58
Low Today
$6.12
Open Price
$6.58
Volume
166.66K
52 Week High
$12.89
52 Week Low
$6.12

NBSE Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

WTFCP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure